US$ 25.67
glp-1 microdose benefits Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 microdosing is popular, but
Description
Researchers are working to understand the effects of these popular new therapies on ocular structures.

Choose online or in-person to master GLP-1s, earn CMEs, and grow your practice.

Between 2025 and 2030, the global pharmaceutical industry faces a Loss of Exclusivity (LOE) wave that puts an estimated $200 billion to $400 billion in branded drug revenue at direct risk.

Specifically, the trial reported an average weight loss of 17.5% and 24.4% at 24 and 48 weeks, respectively
